Article

Ophthalmic surgeries enhanced with innovative TV technologies

Two leading-edge technologies developed by the Japan Broadcasting Co. can help ophthalmic surgeons perform procedures more easily, replacing the traditional ophthalmic microscope, explained Kensaku Miyake, MD, who delivered the Charles D. Kelman Innovator's Lecture during the American Society of Cataract and Refractive Surgery annual meeting.

Two leading-edge technologies developed by the Japan Broadcasting Co. can help ophthalmic surgeons perform procedures more easily, replacing the traditional ophthalmic microscope, explained Kensaku Miyake, MD, who delivered the Charles D. Kelman Innovator's Lecture during the American Society of Cataract and Refractive Surgery annual meeting.

Dr. Miyake, director of the Shohzankai Medical Foundation of the Miyake Eye Hospital, and visiting professor of ophthalmology at the Fujita Health University, Toyoake, Japan, showed the application of a highly sensitive camera (Super-HARP camera) and a three-dimensional high-definition television system for aiding surgeons during cataract and vitrectomy procedures.

The combination of these technologies helps surgeons in a low-illumination operating setting and offers 3-D images in real time. He presented the results of actual human trials.

The technology also can be useful in a classroom setting, for team surgery, and for telesurgery, Dr. Miyake said.

"The new TV system is suited for ophthalmology and other surgical settings because of its high-image quality with high-definition depth and volume," he said. "Also, transmission of compressed images of high quality is now possible at high speed, helping with telemedicine."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
© 2025 MJH Life Sciences

All rights reserved.